NCT00581945 Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00581087 Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults Status UNKNOWN Phase PHASE3
NCT00579046 Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary Disease Status WITHDRAWN Phase PHASE3
NCT00578968 Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation Status COMPLETED Phase PHASE4
NCT00571428 Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD Status COMPLETED Phase PHASE4
NCT00568100 Effect of Pressure Support Ventilation and Neurally Adjusted Ventilatory Assist (NAVA) in Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase NA
NCT00561223 Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase NA
NCT00559910 A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD). Status COMPLETED Phase PHASE2
NCT00556816 Chronic Obstructive Pulmonary Disease (COPD) Outpatient on Demand Clinic Status COMPLETED Phase NA
NCT00546299 Gas Usage for Those With COPD Who Experience Low Oxygen Levels During Activities Only Status COMPLETED Phase NA
NCT00545922 Cognitive Behavioral Therapy for Anxiety and Depression in COPD Status COMPLETED Phase PHASE2
NCT00542282 Vibration Response Imaging in Chronic Obstructive Pulmonary Disease and Asthma Status COMPLETED Phase N/A
NCT00540163 Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced Dyspnoea Status COMPLETED Phase N/A
NCT00532350 Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE1
NCT00531050 Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol Status COMPLETED Phase PHASE2
NCT00525564 Effects of Salmeterol on Walking Capacity in Patients With COPD Status COMPLETED Phase PHASE4
NCT00523367 COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI Status TERMINATED Phase NA